Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Ibuprofen for Postoperative Pain
NCT02254525Phase 3Terminated
- Sponsor
- Biomendi
- Start
- May 2012
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Ibuprofen 800 mg with Placebo (2 arms). Primary endpoint: Efficacy of intravenous ibuprofen for the management of postoperative pain at 24 hours. Started May 2012; status: terminated.
02
Drugs
ibuprofen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02254525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02254525.